Your browser doesn't support javascript.
loading
Sublingual immunotherapy of house dust mite respiratory allergy in China
Cheng, L; Zhou, W-C.
Afiliação
  • Cheng, L; Nanjing Medical University. The First Affiliated Hospital. Department of Otorhinolaryngology. Nanjing. china
  • Zhou, W-C; Nanjing Medical University. The First Affiliated Hospital. Department of Otorhinolaryngology. Nanjing. china
Allergol. immunopatol ; 47(1): 85-89, ene.-feb. 2019. tab
Artigo em Inglês | IBECS | ID: ibc-180777
Biblioteca responsável: ES1.1
Localização: BNCS
RESUMEN
Sublingual immunotherapy (SLIT) has been widely used for the treatment of allergic respiratory diseases, but many problems remain unsolved. Currently available data suggest that SLIT is very effective in children and adults with IgE-mediated respiratory diseases. Most allergists in China generally believe that SLIT is suitable for allergic rhinitis and asthma due to its safety and tolerability. SLIT for three years is suitable for patients to acquire stable therapeutic effects, and the efficacy of single-allergen SLIT for polysensitized patients has also been confirmed. Nevertheless, there are still several factors restricting its application in China, such as the uncertainty of its long-term effects and the prevention of new sensitizations onset, the risk of asthma attacks, the low public awareness of SLIT and poor compliance by patients. This is a narrative review of current evidence on SLIT coming from China
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Asma / Imunoterapia Sublingual Limite: Animais / Humanos País/Região como assunto: Ásia Idioma: Inglês Revista: Allergol. immunopatol Ano de publicação: 2019 Tipo de documento: Artigo Instituição/País de afiliação: Nanjing Medical University/china
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Asma / Imunoterapia Sublingual Limite: Animais / Humanos País/Região como assunto: Ásia Idioma: Inglês Revista: Allergol. immunopatol Ano de publicação: 2019 Tipo de documento: Artigo Instituição/País de afiliação: Nanjing Medical University/china
...